临床试验/CTRI/2020/05/025350

CTRI/2020/05/025350尚未招募2 期

Observational study to assess safety and efficacy of Inj Sepsivac in patients of Covid-19 at R D Gardi Medical College, Ujjain, India

R D Gardi Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

阶段: 2 期
状态: 尚未招募
发起方: R D Gardi Medical College

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

入选标准

•Patients between the age of 18 â?? 65 years diagnosed to have Covid19 infection confirmed by RTPCR assay,
•any one or more of the following
•1. Either an oxygen saturation of 94% or less while the patient was breathing ambient air or a need for oxygen support
•2. Creatinine clearance above 30 ml per minute
•3. Serum levels of ALT and AST less than five times the upper limit of the normal range
•4. Requirement of vasopressor

排除标准

•1.Pregnant or nursing female.
•2.Patient previously enrolled into similar study.
•3.Patient participating or having participated in a clinical trial with another investigational drug within the last 28 days except for investigational drugs against cancer, leukaemia or HIV.
•4.Patients not likely to complete the trial as per judgment of the investigator.

研究者

发起方

R D Gardi Medical College

相似试验

Observational study to find out efficacy and safety of Bifidobacterium longum W11 plus Fructooligosaccharide combination in patients with irritable bowel syndrome

CTRI/2024/07/070510Abbott India Ltd

An observational study of Controlled Release Nitroglycerin in patients with angina.

CTRI/2018/10/016215Care Lifescience Private Limited

Observational study on HAL lower limb model, non medical for non-acute strokeon-acute strokeStroke, non-acute, gait disturbanceD020521

JPRN-jRCT1030220498akajima Takashi10

An observational study of the safety and efficacy of nivolumab as adjuvant treatment for esophageal cancer using the Comprehensive Registry of Esophageal Cancer in the National Clinical Database.Esophageal cancer or esophagogastric cancer

JPRN-UMIN000050925Japanese Foundation For Cancer Research1,750

Observational Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Patients with Chronic hepatitis Dhepatitis D

CTIS2023-504414-29-00Karolinska University Hospital400